Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 57.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

9 May 2018 09:54

RNS Number : 4926N
British Smaller Companies VCT2 Plc
09 May 2018
 

 

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 31 March 2018

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 31 March 2018. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company has continued to make progress in the quarter with total return rising to 114.7 pence per ordinary share. This is an increase of 0.4 pence per ordinary share.

It is pleasing that improved performance across a number of investments contributed to the £0.5 million increase in Net Asset Value ("NAV") from the portfolio in the period.

A number of investments were being held up due t0 delays in HMRC's advance assurance process, but these have now been received, allowing the Company to have a strong start to the year, with investments totalling £4.3 million to date and a successful fundraising. The Company launched a top-up fundraising on 11 January 2018 which was fully subscribed from existing shareholders, closing on 26 January 2018 and raising net proceeds of £4.3 million.

Performance

31 March 2018

Movement

31 December 2017

Net Assets (£m)

63.6

4.5

59.1

NAV per share (PPS)

59.2p

0.4p

58.8p

Cumulative dividends paid (PPS)

55.5p

-

55.5p

Total Return (PPS)

114.7p

0.4p

114.3p

Shares in issue

107,442,275

6,951,700

100,490,575

 

The total return at 31 March 2018, calculated by reference to the NAV per ordinary share and the cumulative dividends paid per ordinary share, was 114.7 pence per ordinary share compared to 114.3 pence per ordinary share at 31 December 2017. Cumulative dividends paid were unchanged at 55.5 pence per ordinary share (31 December 2017: 55.5 pence per ordinary share).

The unaudited NAV per ordinary share as at 31 March 2018 was 59.2 pence per ordinary share (31 December 2017: 58.8 pence per ordinary share) representing an increase of 0.4 pence per ordinary share primarily from the net upward movement in the overall portfolio valuation.

Dividends and shares in issue

On 16 February 2018 the Company issued 7,366,700 ordinary shares as part of the top-up fundraising, raising net proceeds of £4.3m.

On 27 March 2018 the Company purchased 415,000 ordinary shares of 10 pence each at a price of 56.36 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 31 March 2018 was 107,442,275 (31 December 2017: 100,490,575). In addition, at 31 March 2018 the Company held 4,421,351 ordinary shares in treasury (31 December 2017: 4,006,351).

 

Net assets

Net assets at 31 March 2018 comprised the following:

£000

% of net assets

Unquoted investments at fair value

41,951

65.9

Quoted investments at bid price

2,184

3.5

Total investments

44,135

69.4

Cash and cash equivalents

18,367

28.9

Other net current assets

1,126

1.7

Net assets

63,628

100.0

 

The investment portfolio at 31 March 2018 was comprised as follows:

Valuation

£000

Valuation as a % of net assets

Matillion Limited

3,292

5.2

Intelligent Office UK

3,246

5.1

ACC Aviation

3,119

4.9

Mangar Health Limited

2,771

4.4

KeTech Enterprises Limited

2,488

3.9

Eikon Holdco Limited

2,000

3.1

Gill Marine Holdings Limited

1,951

3.1

GTK (Holdco) Limited

1,933

3.0

Business Collaborator Limited

1,865

2.9

Springboard Research Holdings Limited

1,843

2.9

24,508

38.5

Other investments

19,627

30.9

Total investments

44,135

69.4

 

During the quarter to 31 March 2018 the Company made two new investments of £2.0 million into Eikon Holdco Limited, a leading end-to-end digital post-production services provider for the motion picture and broadcast industry and £1.0 million into Ncam Technologies Limited, a provider of innovative and leading Augmented Reality solutions for the entertainment industries. The Company also made a follow-on investment of £0.4 million into Matillion Limited as part of an £18 million series B fundraising that was supported by two US investors.

Since the end of the quarter the Company has invested £0.9 million into Hutchinson Networks Limited, a specialist in the provision of computer networking and data centre services.

In the quarter to 31 March 2018 the realisation and repayment of investments generated cash proceeds of £0.2 million.

Portfolio Performance

Over the quarter to 31 March 2018 the aggregate unrealised portfolio valuation has increased by £0.5 million.

The Board continues to follow its policy of maintaining a diversified portfolio. At 31 March 2018, only two investments represented more than 5 per cent of the Company's NAV.

Outlook

While the UK's economic performance remains subdued the Company's portfolio businesses have continued to adapt their business models and the new investment pipeline remains strong, as shown by the level of investment so far this year. HMRC's recently revised guidance on their advance assurance process could also help to improve the speed at which new investments are made.

As the latest investments show, the composition of the Company's portfolio is changing towards growth capital investments in earlier stage, younger businesses, while the success of the series B fundraising into Matillion demonstrates that the portfolio contains investments with good growth opportunities.

Your Board continues to manage the Company's portfolio in order to maximise the total return and smooth the transition to a period of expected greater volatility of returns through targeted new investments, selective realisations and periodic reviews of the Company's dividend and buy-back policies.

Your Board is committed to delivering long-term value to shareholders through a strong and diversified portfolio.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

9 May 2018

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Jonathan Becher Panmure Gordon (UK) Limited Tel: 0207 886 2715

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRFDMGGKRLLGRZG
Date   Source Headline
22nd Mar 201911:48 amRNSAnnual Financial Report
6th Mar 201911:09 amRNSAppointment of non-executive director
15th Feb 20199:56 amRNSPayment of interim dividend and issue of shares
11th Feb 201911:15 amRNSClose of Offers to New Applications
11th Feb 201911:15 amRNSClose of Offers to New Applications
28th Jan 20193:00 pmRNSUtilisation of over-allotment facility
28th Jan 20193:00 pmRNSUtilisation of over-allotment facility
7th Jan 20192:15 pmRNSDividend Declaration
7th Jan 20191:15 pmRNSStatement re Prospectus
7th Jan 20191:15 pmRNSStatement re Prospectus
21st Dec 20189:13 amRNSDisposal
20th Dec 201810:20 amRNSTransaction in Own Shares
27th Nov 20186:07 pmRNSPublication of Prospectus
27th Nov 20185:49 pmRNSPublication of Prospectus
21st Nov 20181:00 pmRNSUnaudited Interim Results to 30 September 2018
23rd Oct 20181:00 pmRNSStatement re proposed joint fundraising
23rd Oct 20181:00 pmRNSStatement re proposed joint fundraising
28th Sep 20189:54 amRNSPayment of dividend and allotment of shares
27th Sep 20181:27 pmRNSTransaction in Own Shares
17th Aug 20188:07 amRNSHalf-year Report
25th Jun 201811:52 amRNSTransaction in Own Shares
11th May 201810:01 amRNSPayment of final dividend and allotment of shares
9th May 20182:36 pmRNSResult of Annual General meeting
9th May 20189:54 amRNSInterim Management Statement
28th Mar 20188:27 amRNSTransaction in Own Shares
16th Mar 20181:43 pmRNSAnnual Financial Report
16th Feb 20189:50 amRNSIssue of Equity
12th Feb 201810:50 amRNSDirector Declaration
26th Jan 20189:24 amRNSClose of Offer to New Subscriptions
11th Jan 20188:06 amRNSOffer for Subscription
20th Dec 20178:50 amRNSPurchase of own securities and total voting rights
20th Dec 20178:50 amRNSLaunch of Top-up Offer
30th Nov 20171:28 pmRNSInterim Management Statement to 30 September 2017
20th Oct 20172:12 pmRNSTransaction in Own Shares
29th Sep 20179:47 amRNSPayment of interim dividend and issue of shares
29th Sep 20179:36 amRNSTransaction in Own Shares
23rd Aug 20176:00 pmRNSHalf-year Report
26th Jun 201710:58 amRNSTransaction in Own Shares
12th May 201710:11 amRNSPayment of Final Dividend and Allotment of Shares
10th May 20172:57 pmRNSAGM Statement
10th May 20179:51 amRNSInterim Management Statement
13th Apr 20171:47 pmRNSTransaction in Own Shares
21st Mar 20171:25 pmRNSAnnual Financial Report
10th Feb 201710:47 amRNSIssue of Equity and Close of Offer
30th Jan 20172:07 pmRNSOffer for Subscription
10th Jan 201710:25 amRNSClose of Offer to new Subscriptions
3rd Jan 201711:59 amRNSOffer for Subscription
6th Dec 201610:06 amRNSChange of Stockbrokers
29th Nov 20169:46 amRNSPurchase of own securities and total voting rights
22nd Nov 20163:30 pmRNSInterim Management Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.